REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Szennaphar Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SZENNAPHAR Gyogyszereszeti Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Szennaphar Bt. is a company based in Hungary, with its head office in Kiskunfelegyhaza. It operates in the Pharmacies and Drug Stores industry. It was established on June 10, 1997. It currently has a total number of 9 (2024) employees. In 2023, the company reported a net sales revenue increase of 14.09%. Its’ total assets recorded a growth of 4.61%. Szennaphar Bt.’s net profit margin increased by 0.44% in 2023.

Headquarters
Korond utca 5.
Kiskunfelegyhaza; Bacs-Kiskun; Postal Code: 6100

Contact Details: Purchase the Szennaphar Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Szennaphar Bt. report to view the information.
Outstanding Shares:
Purchase the Szennaphar Bt. report to view the information.
Registered Capital:
Purchase the Szennaphar Bt. report to view the information.
Financial Auditors:
Purchase the Szennaphar Bt. report to view the information.
Incorporation Date:
June 10, 1997
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Szennaphar Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.09%▲
Total operating revenue
15.09%▲
Operating profit (EBIT)
25.21%▲
EBITDA
21.99%▲
Net Profit (Loss) for the Period
25.55%▲
Total assets
4.61%▲
Total equity
6.51%▲
Operating Profit Margin (ROS)
0.47%▲
Net Profit Margin
0.44%▲
Return on Equity (ROE)
5.05%▲
Quick Ratio
-0.04%▼
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo